Convergent Germline Mutations in TP53 and BRCA1 Driving Multi-lineage Metachronous Malignancies: A Familial Case of Overlapping Li-Fraumeni and Hereditary B

This extraordinary case illustrates a rare convergence of two overlapping hereditary cancer syndromes – Li-Fraumeni syndrome (LFS) and hereditary breast and ovarian cancer (HBOC), driven by germline mutations in TP53 and BRCA1 , respectively, and manifesting as five distinct malignancies across the lifetime of a single patient. Hereditary cancer syndromes are often defined by singular germline mutations; however, the coexistence of multiple pathogenic variants in tumour suppressor genes may profoundly alter the phenotypic landscape. The functional intersecting overlap of these genes – governing genome stability, DNA repair and cell cycle regulation – forms a core tumour suppressor network. Disruption across co-existing germline mutations creates a uniquely permissive environment for tumorigenesis. The clinical implications of such multigenic inheritance are poorly understood due to their rarity. We report a case of a female patient with dual germline TP53 and BRCA1 , and subsequently, development of new somatic profiling revealed additional oncogenic events as second hit BRAF V600E, RB1, FGFR3 and IDH2 mutations who developed a constellation of malignancies over time. This report aims to dissect the molecular chronology, explore mechanistic synergies and highlight implications for targeted therapy, surveillance and counselling.